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Abstract The improvement of surgical techniques resulted
in significant life prolongation of many young patients with
congenital heart disease (CHD). However, as these patients
reach adulthood, their risk for late complications associated
with surgery is also increased. One of the most difficult
challenges associated with CHD is the high incidence of
cardiac arrhythmias that arise from either the myocardial
substrate created by abnormal physiology (pressure/volume
changes, septal patches, and suture lines) or the presence of
surgical scar. Catheter ablation is proven to be effective in
treating atrial and ventricular arrhythmias in structurally
normal hearts, and has also been used to treat arrhythmias
in adults with congenital heart disease. In this review we
provide an overview about diagnostic challenges, mapping
and ablation techniques and outcome of patients undergo-
ing transcatheter ablation procedures.
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1 Background
Arrhythmias associated with congenital heart disease
encounter major diagnostic and therapeutic challenges for
the treating physicians. Moreover, this very special patient
group—often called GUCH (Grown Ups with Congenital
Heart defects)—is followed-up in different clinical settings
including pediatric cardiologists, congenital heart special-
ists, general cardiologists and rhythm-specialists—all
depending on local organizations and the magnitude of
the driving symptoms. Recurrent atrial tachycardias late
after corrective or palliative surgery in patients with
complex congenital heart disease (CHD) contribute consid-
erably to the morbidity and mortality of this special group
of patients [1]. Therefore, arrhythmia treatment is a key
issue in the long-term outcome of these patients. All kind of
arrhythmias can occur, and these arrhythmias are some-
times very challenging especially when only 12-lead ECGs
are available. Based on the history of previous surgery and
significant chamber dilatation, hypertrophy and fibrosis,
atrial tachycardias in CHD patients often are macro
reentrant tachycardias (MRAT) [1–5]. Certainly in many
patients, atrial tachycardia has a focal mechanism. Viable
myocardial fibers embedded within areas of scar tissue play
a pivotal role in the initiation and perpetuation of macro
reentrant tachycardias. Previous surgery and pathophysio-
logical mechanisms involving the ventricles can cause
ventricular arrhythmias. Catheter ablation may be a curative
treatment for most atrial tachycardias in CHD patients and
certainly might play a role in the treatment of ventricular
tachycardias as well. The aim of the present review is
provide about the most important diagnostic challenges and
the most important approaches in the transcatheter ablative
treatment of patients with CHD.
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Patients with congenital heart disease (CHD) have an
increased risk to develop arrhythmias [1, 5–7]. The high
incidence of cardiac arrhythmias in the patients with CHD
is either a result of coexisting congenital abnormalities of
the specialized conduction system (congenital arrhythmo-
genic substrates) or may occur in response to hemodynamic
influences on chamber dimensions, muscle mass, metabo-
lism of myocardial tissue (acquired arrhythmogenic sub-
strates) [7, 8]. The best-known example of frequent
association of congenital arrhythmogenic substrates with
congenital defects is the accessory pathway (AP) associated
with right-sided AV valve malformation. APs coexist in
more than 25% of the patients with Ebstein anomaly [9].
Alterations in hemodynamics in CHD such as, chronic
volume and pressure overload, cyanosis, myocardial hyper-
trophy and fibrosis, varying degrees of pulmonary hyper-
tension and ventricular dysfunction all contribute to
arrhythmogenesis.
Moreover, over the past few decades, surgical advances
have helped to prolong the lives of many young patients
with congenital heart disease but at the same time created
the substrate for higher rate of acquired cardiac arrhythmias
[7]. Septal patches, suture lines, surgical scars are super-
imposed on the myocardial substrate created by abnormal
pressure/volume changes. Arrhythmias have been described
as long-term complications after almost every form of
cardiac surgery. However, certain combinations of CHD
and surgical approaches seem to be associated with even
higher rate of occurrence. These include surgeries involving
an atriotomy or other significant surgical manipulation of
the atrium, such as atrial septal defect repair, Mustard and
Senning operations, Fontan anastomoses, tetralogy of Fallot
and repair of anomalous pulmonary venous connection [7].
More than one quarter of patients who have undergone the
Fontan and Mustard procedures have inducible sustained
atrial tachycardias [5, 7, 10, 11].
3 Diagnostic challenges
The crucial point of creating the best strategy for ablation is
to determine the right mechanism and the chamber of origin
of tachyarrhythmias. In atrial tachycardia differentiating
between a focal and reentry mechanism is often more
difficult than in patients without structural heart disease.
Obviously, micro-reentry tachycardias have a significant
role in causing uncertainty in this process. Recently, a large
number of algorithms became available including 12-lead
ECG based approaches as well [12, 13].
There has been growing interest in elucidating the
mechanism of atrial tachycardias and in locating the atrium
of origin with the purpose of arrhythmia cure [13]. The
surface ECG does not always provide good accuracy in
predicting the chamber of origin. It is well known that even
if the tachycardia demonstrates typical atrial flutter mor-
phology, it still can be non-isthmus dependent. It is also
known that even if the ECG is suggestive for FAT (focal
atrial tachycardias), one may still have to deal with a
MRAT (macro re-entrant atrial tachycardia). Eventually, the
coexistence of more than one intra-atrial reentrant circuit
cannot be excluded or predicted based on the 12-lead ECG
alone [14]. For understanding the mechanisms of FATs an
analogy can be drawn with normal impulse conduction. The
sinus impulse for instance, which is more or less focal in
origin, rarely takes more than 120 ms to spread over both
atria when recorded with multipolar catheter configurations
covering both atria. Regardless whether the pacemaker is
the sinus node or an abnormal focus elsewhere in the atria,
the activation front still spreads radially and it is rather hard
to suppose that the time of the biatrial activation in FAT
would be much longer than in normal sinus rhythm. Based
on this, using two multipolar catheters in the heart (right
atrium and coronary sinus) the biatrial activation recorded
by these two catheters can serve as a basic measure to
elucidate the mechanism of AT. Based on previous
experience biatrial activation is almost always less than
40% of the whole tachycardia cycle length for FAT [13].
This can be used as a simple value for discrimination.
Moreover, the ratio of RAA (right atrial activation) time
related to TCL does not show any overlap between FATand
MRAT. It is known that in FATarising from the LA close to
the ostium of the right-sided pulmonary veins or at the
superior part of the mitral annulus, the earliest atrial
activation may be recorded in the posterior or septal area
of the RA or at the terminal crest, and may precede the
activation recorded at the CS. This is not surprising given
the fact that the right superior pulmonary vein enters the
LA just behind the superior cavoatrial junction and the right
inferior pulmonary vein—behind the posterior RA wall
midway between the superior and inferior cavoatrial
junctions. As a matter of fact, the septal part of the RA is
more leftward situated than the right lateral part of the LA
where the pulmonary veins join it. This also explains the
fact that in FAT, the earliest atrial activation taken in
isolation as recorded by fixed position catheters is not a
good predictor for the chamber of origin. It is known that in
FAT originating from the left pulmonary veins, the
activation of CS is from distal to proximal. If the direction
of activation is proximal to distal, the focus can be within
the RA or the LA near the right superior pulmonary vein. In
MRAT, the activation front is circulating over a more or
less large circuit from which it spreads out to the rest of
the atria. When a multipolar catheter is deployed over the
circuit or over a part of it, each electrode pair records the
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constitute the TCL. If the catheter has enough electrode
pairs with sufficient density, an atrial potential would be
recorded virtually at every time point of TCL because the
impulse is circulating continuously over the same path.
4 Mapping techniques
Inducibility, stability and the duration of the index
arrhythmia determine the mapping possibilities in patients
with CHD [15]. Obviously, a stable and sustained arrhyth-
mia allows sequential data acquisition so as to perform
activation mapping. This can be conventional activation
mapping, 3D activation mapping and/or entrainment map-
ping [6, 13, 15]. Contrary to this, when the arrhythmia
exhibits unstable activation sequences, or changing con-
duction times, mapping in sinus rhythm may be necessary.
Mapping may also be useful after cardioversion in order to
locate fixed barriers. In patients without inducible arrhyth-
mia, a similar strategy can be useful.
4.1 Entrainment mapping
In atrial macroreentrant tachycardia, understanding the
underlying reentrant circuit is the key to successful ablation
[6, 16]. Differentiating the right and left atrial origins of the
tachycardia is of crucial importance for planning the
procedure and for predicting the procedure’s outcome and
possible complications. Unfortunately, this determination
may be difficult, especially if intra-atrial and interatrial
conduction have already been altered by previous right and
left atrial ablation, for example, after ablation for atrial
fibrillation. Entrainment mapping is an established electro-
physiologic technique that was first described in the 1980s
and has been used since to delineate the localization of
reentrant circuits. The most important criterion for deter-
mining whether a pacing site is located inside the reentrant
circuit is the difference between the post-pacing interval
(PPI) and the tachycardia cycle length (TCL). If the
difference is 20 to 30 ms, the pacing site probably is
located inside the reentrant circuit. However, delineating a
reentry using this technique can be laborious and time-
consuming because pacing from multiple sites is necessary.
4.2 Three-dimensional electroanatomical mapping
With the development ofthree-dimensional mappingsystems,
visualizationoftheentireelectricalactivationsequenceduring
atrial reentrant tachycardia on the reconstructed anatomy of
the right andleftatria becamepossible[17]. Differentiation of
the active atrium harboring the reentrant circuit from the
passively activated atrium now is possible, but only after
complete mapping of at least one atrium. Hence, a fast and
easy way for distinguishing a right atrial from a left atrial
origin of reentrant tachycardia is still lacking. Using 3D
mapping as a single tool is therefore not recommended. Bi-
atrial mapping improves diagnostic accuracy significantly.
Furthermore, in a significant number of patients bi-atrial
involvement is present, requiring bi-atrial ablation.
4.3 Dual loop circuits
The presence of more than one loop in postsurgical atria is
the most challenging issue during transcatheter ablation
procedures [18]. Dual-loop circuits should be anticipated
and systematically approached in patients with IART late
after open-heart surgery. The most important sign is sudden
change of tachycardia CL and/or activation sequence during
RF ablation. Tachycardia transformation is strongly sugges-
tive for dual-loop IART but hard to notice in some cases
[18]. Therefore reconfirmation using of entrainment mapping
data at critical sites before catheter ablation and after
tachycardia change aids in establishing the diagnosis. The
circuits delineated so far have a distinctive pattern including
an isthmus dependant atrial flutter and a periatriotomy
circuit. Electroanatomic mapping appears useful to delineate
the tachycardia isthmus of periatriotomy circuits.
5 Transcatheter ablation of patients with the most
common malformations
5.1 Arrhythmias after ASD repair
The most common arrhythmias associated with ASD’ are
regular ATs and atrial fibrillation [7, 17, 19]. The trans-
catheter approaches to atrial fibrillation is beyond the scope
of this review. For the treatment of AT different strategies
are described. Three-dimensional electroanatomical map-
ping allows reconstruction of AT mechanisms and repre-
sents an advance in the precise localization and ablation of
the arrhythmogenic substrate of post-surgical AT. Intra-
atrial macroreentrant mechanisms represented most of the
mechanisms in most recent publications [20]. These are
most often dependent on a narrow isthmus bounded by a
line of double potentials related to the surgical incision. A
much smaller number of patients develop tachycardias
related to a focus of abnormal tissue adjacent to a right
atrial incision or suture site. Ablation of both mechanisms
can be performed with a high success rate.
5.2 Ebstein’s anomaly
The deformity and displacement of the tricuspid valve can
have serious hemodynamic consequences such as tricuspid
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malities along with the frequent coexistence of atrial septal
defects predispose to the development of arrhythmias.
However, in this group of patients congenital arrhythmia
substrates such as accessory pathways can make the
spectrum very complex. Variants of accessory pathways
such as Mahaim fibers are more common in this condition.
Results of radiofrequency catheter ablation in Ebstein’s
anomaly for the treatment of AP and incisional MRAT are
somewhat more disappointing than in patients without the
anomaly. The factors contributing to this is clearly related
to the complex geometry, location of the pathways in the
atrialized portion of the right ventricle, the distorted AV
ring and the presence of multiple accessory pathways.
Moreover, higher recurrences rates are also reported in
patients with Ebstein’s anomaly.
5.3 Transposition of the great arteries: arrhythmias
after the Senning and Mustard operation
The Mustard and Senning operations were developed to
correct the physiologic abnormality by forming a baffle
within the atria to switch the flow of blood at the inflow
level. The arterial switch operation was subsequently
created to enable the left ventricle to become the systemic
ventricle. The Mustard repair requires extensive incisions
and suture lines in the atria. This results in intra-atrial
conduction delays and abnormalities in atrial refractoriness,
creating the substrate for atrial flutter [11, 16, 21]. Risk
factors for supraventricular tachycardia include pulmonary
hypertension, systemic ventricular dysfunction, and child-
hood junctional rhythm. Loss of sinus rhythm has been
associated with previous septectomy, postoperative brady-
cardia, late atrial flutter, and preoperative arrhythmia. This
loss of sinus rhythm is in contrast to the long-term
maintenance of sinus rhythm in 95–98% of arterial switch
patients. The incidence of supraventricular tachycardia is
also significantly lower, with a rate of 5% in arterial switch
patients, compared to 48% in Mustard patients. Catheter
ablation has been employed with a high acute success rate,
and a moderate 10% rate of recurrence. The isthmus of
tissue between the tricuspid valve and inferior vena cava
orifice, the area of the mouth of the coronary sinus, and the
region extending from the mouth to the tricuspid annulus
are critical components in the reentry circuit. Intra-atrial
reentry may involve either atrium and requires a retrograde
aortic approach in most cases leading to biatrial ablation.
Even cavotricuspid isthmus ablation requires bi-atrial
Fig. 1 CARTO 3D activation map showing bi-atrial activation map in
a patient with atrial flutter associated with Senning operation. The
activation shows cavotricuspid dependent atrial flutter with bi-atrial
involvement
Fig. 2 Ablation of Figure 8 type
dual loop macroreentry in a
patient long after the correction
of tetralogy of Fallot. The left
panel shows the activation map
with the ablation points (red
dots), while the right panel
demonstrates integration with
the magnetic navigation system
164 J Interv Card Electrophysiol (2008) 22:161–166ablation in most patients (Fig. 1). In addition, focal atrial
tachycardia has been localized adjacent to baffle suture lines.
5.4 Tetralogy of Fallot
Patients with this condition are predisposed to both ventric-
ular and atrial arrhythmias [1, 3, 10, 22, 23]. Therefore, the
differential diagnosis is a crucial step in the early
management of the patients. Ventricular arrhythmias have
a prevalence of 4–7% and the 12-lead ECG usually shows
right ventricular outflow tract type morphology [23, 24].
On top of this, more than one third of TOF patients
manifest atrial arrhythmias [3]. Risk factors include older
age at operation, increased atrial size, tricuspid or pulmo-
nary regurgitation and ventricular dysfunction. Atrial flutter
and atrial fibrillation were more common in patients who
had long-lasting pulmonary artery shunts, early operations
for residual hemodynamic lesions, older age at repair, and
moderate-to-severe tricuspid regurgitation [25]. Catheter
ablation is successful in patients with atrial flutter and VT.
A scar tissue caused by the corrective surgery should be
identified for successful ablation. An ablation line between
the lower margin of the scar and the inferior vena cava is
associated with a high success rate, with a moderate
recurrence rate (Fig. 2). VT’s are usually localized to the
right ventricular outflow tract and the infundibulotomy scar
or the septal surface of the VSD patch repair. Interestingly
enough, beyond the high immediate success rate, these pro-
cedures are associated with very low rate of recurrences [4].
5.5 Fontan circulation and ablation procedures
Older variants of the Fontan procedure such as the right
atrium-pulmonaryarteryconnection,havegivenwaytonewer
modifications such as the lateral tunnel and external conduit,
which reduce the distention of the right atrium [5, 26]. In
response to chronic stretching secondary to persistent
pressure overload, the Fontan right atrium remodels and
dilates [27]. This occurs in parallel to the change in
electrophysiological properties manifested by the atrial
conduction delay and the imbalance of the conduction
heterogeneity. There are certain risk factors for early
postoperative arrhythmias such as atrioventricular AV valve
regurgitation. Older age at operation is also a risk factor in
almost all congenital malformations [27]. Atrial arrhythmias
develop in a very high percentage of patients. Patients who
develop atrial arrhythmias have more severe co-morbidities
including heart failure, and right atrial thrombus. CA is
associated with a surprisingly high acute success rate of
more than 80% with a relatively high (20%) incidence of
recurrences. The most common arrhythmia substrates are
located in the region of the Fontan anastomosis, the lateral
right atrial wall and the inferior right atrium [28].
6 The possible role of novel navigation technologies
in catheter ablation of CHD patients
Developments allowing better navigation and 3D image
integration may improve outcome of catheter ablation
procedures in GUCH patients. One of the most promising
technologies is magnetic navigation (Fig. 2). There are
theoretical advantages of using magnetic navigation appli-
cable for these complex and challenging anatomical
situations. One of the potential advantages of the system
is the utilization of a non-traumatic, very floppy catheter. It
reduces the risk for perforation, and it can easily pass
fenestrations associated with previous surgery. Another
advantage is the superior navigation capability. Certainly,
increased stability might provide better transmural lesions
as well. The combination of navigation and 3D imaging
such as CT, MRI and ultrasound will further improve
success rate and theoretically can play a role in decreasing
arrhythmia recurrences.
7 Conclusions
Atrial tachycardia in patients with surgically corrected CHD
is usually caused by a macroreentrant mechanism. Howev-
er, atrial tachycardia is caused by a focal mechanism in a
considerable number of patients. Moreover exact determi-
nation of the chamber of origin is essential for the
appropriate ablation strategy. Areas of abnormal conduction
may be the crucial pathway within a large reentrant circuit,
but they also may be the site of origin of a focal atrial
tachycardia and thus play an important role in the
pathogenesis of these atrial tachycardias. Catheter ablation
directed at areas of abnormal conduction (“source abla-
tion”) is mostly effective in these patients. Novel guiding
and mapping tools improve the efficacy of ablation,
however full integration with catheter technology is still
an important issue to be solved.
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